Statin Use and Survival in Early Breast Cancer According to Different Intrinsic Subtypes - Takeaways - MDSpire

Statin Use and Survival in Early Breast Cancer According to Different Intrinsic Subtypes

  • By

  • Santeri Palmi

  • Otso Arponen

  • Mika Murto

  • Aino Siltari

  • Arja Jukkola

  • Teemu Murtola

  • June 2, 2026

  • 0 min

Share

  • 1

    Breast cancer was the most frequently diagnosed cancer and leading cause of cancer-related deaths among females globally in 2022.

  • 2

    Statins are commonly prescribed for cardiovascular disease prevention and have shown potential anticancer properties in breast cancer.

  • 3

    Previous studies suggest statin use may improve survival in breast cancer patients, but most focused on advanced stages rather than early-stage disease.

  • 4

    The study aims to assess the impact of prediagnostic and postdiagnostic statin use on survival outcomes in early-stage breast cancer across intrinsic subtypes.

  • 5

    Data for the study was collected from a population-based cohort of female patients diagnosed with invasive breast cancer in Finland from 1995 to 2013.

Original Source(s)

Statin Use and Survival in Early Breast Cancer According to Different Intrinsic Subtypes

  • by Santeri Palmi, Otso Arponen, Mika Murto, Aino Siltari, Arja Jukkola, Teemu Murtola

  • June 2, 2026

Related Content

Case Report: A rare triad of neoplasms: navigating synchronous accessory breast cancer, papillary thyroid carcinoma, and inflammatory nasal papilloma

Case Report: A case of a pregnancy-associated breast cancer patient with a pathogenic variant in BRCA1 who underwent staged risk-reducing salpingo-oophorectomy and contralateral risk-reducing mastectomy

Longitudinal predictor analysis of pain in breast cancer survivors on aromatase inhibitors—the PAC-WOMAN trial